Literature DB >> 21596843

Oxidative stress and mitochondrial dysfunction in sepsis.

H F Galley1.   

Abstract

Sepsis-related organ dysfunction remains the most common cause of death in the intensive care unit (ICU), despite advances in healthcare and science. Marked oxidative stress as a result of the inflammatory responses inherent with sepsis initiates changes in mitochondrial function which may result in organ damage. Normally, a complex system of interacting antioxidant defences is able to combat oxidative stress and prevents damage to mitochondria. Despite the accepted role that oxidative stress-mediated injury plays in the development of organ failure, there is still little conclusive evidence of any beneficial effect of systemic antioxidant supplementation in patients with sepsis and organ dysfunction. It has been suggested, however, that antioxidant therapy delivered specifically to mitochondria may be useful.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596843     DOI: 10.1093/bja/aer093

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  176 in total

1.  The role of the E2F1 transcription factor in the innate immune response to systemic LPS.

Authors:  Laura A Warg; Judy L Oakes; Rachel Burton; Amanda J Neidermyer; Holly R Rutledge; Steve Groshong; David A Schwartz; Ivana V Yang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-15       Impact factor: 5.464

Review 2.  Strategies to combat chronic critical illness.

Authors:  Jennifer M Maguire; Shannon S Carson
Journal:  Curr Opin Crit Care       Date:  2013-10       Impact factor: 3.687

Review 3.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

4.  Mesenchymal Stromal Cells Deficient in Autophagy Proteins Are Susceptible to Oxidative Injury and Mitochondrial Dysfunction.

Authors:  Sailaja Ghanta; Konstantin Tsoyi; Xiaoli Liu; Kiichi Nakahira; Bonna Ith; Anna A Coronata; Laura E Fredenburgh; Joshua A Englert; Claude A Piantadosi; Augustine M K Choi; Mark A Perrella
Journal:  Am J Respir Cell Mol Biol       Date:  2017-03       Impact factor: 6.914

Review 5.  Sepsis pathophysiology and anesthetic consideration.

Authors:  Koichi Yuki; Naoka Murakami
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2015

6.  Beta-blockers in patients with septic shock: plenty of promise, but no hard evidence yet.

Authors:  Won-Young Kim; Sang-Bum Hong
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

7.  Effects of S-allyl cysteine on lung and liver tissue in a rat model of lipopolysaccharide-induced sepsis.

Authors:  Orhan Bayraktar; Neslihan Tekin; Ozlem Aydın; Fahrettin Akyuz; Ahmet Musmul; Dilek Burukoglu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-12-06       Impact factor: 3.000

8.  Scavenging of reactive oxygen and nitrogen species with nanomaterials.

Authors:  Carolina A Ferreira; Dalong Ni; Zachary T Rosenkrans; Weibo Cai
Journal:  Nano Res       Date:  2018-05-26       Impact factor: 8.897

9.  Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury.

Authors:  Jing-Hui Chen; Gao-Feng Yu; Shang-Yi Jin; Wen-Hua Zhang; Dong-Xu Lei; Shao-Li Zhou; Xing-Rong Song
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Poly (ADP-ribose) synthetase inhibitor has a heart protective effect in a rat model of experimental sepsis.

Authors:  Lianshuang Zhang; Jinpeng Yao; Xifeng Wang; Hongxing Li; Tongshen Liu; Wei Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.